Kesatuan Eropah - Czech - EMA (European Medicines Agency)

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

Republik Czech - Czech - SUKL (Státní ústav pro kontrolu léčiv)

zentiva a.s., bratislava array - 4979 hemihydrÁt kalium-hydrogen-aspartÁtu; 4982 tetrahydrÁt magnesium-hydrogen-aspartÁtu - tableta - 0,175g/0,175g - draslÍk

Republik Czech - Czech - SUKL (Státní ústav pro kontrolu léčiv)

biomedica, spol. s r.o., praha array - 1174 chlorid draselnÝ - enterosolventní tableta - 500mg - chlorid draselnÝ

Republik Czech - Czech - SUKL (Státní ústav pro kontrolu léčiv)

bausch health ireland limited, dublin array - 1174 chlorid draselnÝ - tableta s prodlouženým uvolňováním - 1g - chlorid draselnÝ

Kesatuan Eropah - Czech - EMA (European Medicines Agency)

zentiva, k.s. - pregabalin - anxiety disorders; epilepsy - antiepileptika, - neuropathic pain , pregabalin zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , epilepsy , pregabalin zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , generalised anxiety disorder , pregabalin zentiva is indicated for the treatment of generalised anxiety disorder (gad) in adults.

Kesatuan Eropah - Czech - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotické činidla - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Republik Czech - Czech - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 15519 pregabalin - tvrdá tobolka - 150mg - pregabalin

Republik Czech - Czech - SUKL (Státní ústav pro kontrolu léčiv)

stada arzneimittel ag, bad vilbel array - 15519 pregabalin - tvrdá tobolka - 75mg - pregabalin

Republik Czech - Czech - SUKL (Státní ústav pro kontrolu léčiv)

vivanta generics s.r.o., praha array - 15519 pregabalin - tvrdá tobolka - 150mg - pregabalin

Republik Czech - Czech - SUKL (Státní ústav pro kontrolu léčiv)

vivanta generics s.r.o., praha array - 15519 pregabalin - tvrdá tobolka - 300mg - pregabalin